91 related articles for article (PubMed ID: 5427314)
21. [Letter: Dextro propoxyphene--supplementing facts about Dolotard].
Aggerbeck B
Lakartidningen; 1976 Jun; 73(24):2248-9. PubMed ID: 933618
[No Abstract] [Full Text] [Related]
22. New warning on propoxyphene.
FDA Drug Bull; 1979 Sep; 9(4):22-3. PubMed ID: 488581
[No Abstract] [Full Text] [Related]
23. Deaths involving propoxyphene. A study of 41 cases over a two-year period.
Sturner WQ; Garriott JC
JAMA; 1973 Mar; 223(10):1125-30. PubMed ID: 4739371
[No Abstract] [Full Text] [Related]
24. Propoxyphene warning.
FDA Drug Bull; 1978; 8(2):14. PubMed ID: 631470
[No Abstract] [Full Text] [Related]
25. Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France.
Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746528
[No Abstract] [Full Text] [Related]
26. It is time to remove propoxyphene from clinical practice.
Lipman AG
J Pain Palliat Care Pharmacother; 2009; 23(2):104-5. PubMed ID: 19492210
[No Abstract] [Full Text] [Related]
27. Propoxyphene dependence: an update.
Collins GB; Kiefer KS
Postgrad Med; 1981 Dec; 70(6):57-61. PubMed ID: 7312731
[TBL] [Abstract][Full Text] [Related]
28. Dextropropoxyphene: welcome withdrawal from a French hospital's formulary.
Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18629970
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of propoxyphene napsylate compound in post partum uterine cramping.
Bauer RO; Baptisti A; Gruber CM
J Med; 1974; 5(6):317-28. PubMed ID: 4606533
[No Abstract] [Full Text] [Related]
30. Adverse interaction between propoxyphene and phenelzine.
Zornberg GL; Hegarty JD
Am J Psychiatry; 1993 Aug; 150(8):1270-1. PubMed ID: 8328578
[No Abstract] [Full Text] [Related]
31. Drug therapy reviews. Propoxyphene: a review.
Miller RR
J Maine Med Assoc; 1977 Mar; 68(3):86-9, 103-9. PubMed ID: 320282
[No Abstract] [Full Text] [Related]
32. Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.
Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
Toxicol Appl Pharmacol; 1971 Jul; 19(3):480-92. PubMed ID: 4936997
[No Abstract] [Full Text] [Related]
33. [Hepatotoxicity caused by dextropropoxyphene. Two cases, one of them with recurrence].
Desruelles F; Chichmanian RM; Castanet J; Rodot S; Lacour JP; Ortonne JP
Therapie; 1994; 49(6):521-2. PubMed ID: 7878621
[No Abstract] [Full Text] [Related]
34. [Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders].
Aglas F; Fruhwald FM; Chlud K
Acta Med Austriaca; 1998; 25(3):86-90. PubMed ID: 9816400
[TBL] [Abstract][Full Text] [Related]
35. Aspirin stability in propoxyphene compound products.
Brown AW; Ball WD
Am J Hosp Pharm; 1977 Jul; 34(7):674. PubMed ID: 888827
[No Abstract] [Full Text] [Related]
36. [Proctitis following the prolonged use of dextropropoxyphene and paracetamol suppositories: the risk persists despite change of excipient].
Marteau P; Flourié B; Froguel E; Contou JF; Galian A; Rambaud JC
Gastroenterol Clin Biol; 1990; 14(1):102-3. PubMed ID: 2311842
[No Abstract] [Full Text] [Related]
37. Propoxyphene: a review.
Miller RR
Am J Hosp Pharm; 1977 Apr; 34(4):413-23. PubMed ID: 16489
[TBL] [Abstract][Full Text] [Related]
38. Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene.
Marraffa JM; Lang L; Ong G; Lehmann DF
Clin Pharmacol Ther; 2006 Mar; 79(3):282-6. PubMed ID: 16513452
[TBL] [Abstract][Full Text] [Related]
39. Physicians asked to write 'No Refill' on propoxyphene Rxes.
FDA Drug Bull; 1980 Jul; 10(2):11. PubMed ID: 7399191
[No Abstract] [Full Text] [Related]
40. Propoxyphene: an example of the need for increased pharmacist/patient interaction.
Kennedy DL; Burke LB
Am Pharm; 1979 Sep; 19(10):45-6. PubMed ID: 539538
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
